Viewing Study NCT06754761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:09 PM
Ignite Modification Date: 2026-02-04 @ 2:35 AM
Study NCT ID: NCT06754761
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-01
First Post: 2024-11-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ovarian cancer View
None non-small cell lung cancer View
None endometrial cancer View
None hADME, bioavailability View
None AZD6738 View
None ceralasertib View